Lilly third quarter profit falls 8% on higher costs -Breaking
[ad_1]
© Reuters. FILE PHOTO A pharmaceutical manufacturing facility of Eli Lilly and Company is shown at 50 ImClone Dr in Branchburg (New Jersey), March 5, 2021. REUTERS/Mike Segar/File Photo(Reuters) – Eli Lilly (NYSE 🙂 and Co reported Tuesday a 8% drop in profit for the third quarter, attributed to higher development and research costs.
From $1.21billion or $1.33 per shares a year ago, net income dropped to $1.11billion or $1.22 per stock in the third quarter.
Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]